US2009286313A1PendingUtilityA1
Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
Est. expirySep 8, 2020(expired)· nominal 20-yr term from priority
C07K 14/495C07K 14/4747G01N 33/5082A01K 2217/05A61P 35/00G01N 2500/10
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides methods and compositions for drug screens to identify and characterize agents that are agonistic or antagonistic to activation of the promoter region of the NAG-1 gene. Activation of the NAG-1 gene is associated with the apoptotic elimination of cancer cells both in vitro and in vivo. The invention also provides novel promoter region sequences of the NAG-1 gene.
Claims
exact text as granted — not AI-modified1 - 14 . (canceled)
15 . An isolated or purified antibody reactive with a polypeptide encoded by a nucleic acid sequence comprising SEQ ID NO: 2.
16 . A composition comprising the isolated or purified antibody of claim 15 .
17 . A host cell comprising the isolated or purified antibody of claim 15 .Join the waitlist — get patent alerts
Track US2009286313A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.